Stratasys (NSDQ:SSYS) and Origin announced that they signed an agreement to produce more than 1 million nasopharyngeal COVID-19 testing swabs per week. Under the agreement, Stratasys is slated to market and promote Origin’s 3D-printed swabs to healthcare providers and other U.S. testing centers. Each Origin One 3D printer can produce batches of 1,500 Origin NP O1 swabs at […]
Origin
Software is enabling medical 3D printing innovation: Here’s how
The 3D printers themselves get a lot of attention, but for 3D-printing to become ubiquitous in the medtech space, software will have to play a key role. A 3D printer without software to tell it where to place the material is a really nice, expensive coffee table, according to Scott Rader, a former Stratasys GM […]
Origin treats first patients in study of nitric oxide for diabetic foot ulcers
Origin said today that it treated the 1st patients in its dose-ranging Genesis Phase IIb-equivalent trial. The study is evaluating therapeutic quantities of plasma-generated nitric oxide as a treatment for chronic diabetic foot ulcers. The 27-week trial is slated to enroll up to 100 patients. Patients will be randomized into 1 of 4 dosing regimens, […]